MVMatthijs Vynck

Matthijs Vynck

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Matthijs Vynck has a total of 212 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A validated dual-extraction approach for comprehensive ultra-high performance liquid chromatography-high resolution mass spectrometry-based metabolomics and lipidomics of human placenta applied to the ENVIRONAGE birth cohort

    by Adam Cseresznye, Matthijs Vynck, Liesa Engelen, Fatima Den Ouden, Elias Maris, Sebastian Proost, Arnau Vich i Vila, Lieselot Hemeryck, Giulia Poma, Roger Pero-Gascon, et al.

    The placenta is the interface between maternal exposome and fetal development. However, analytical platforms for simultaneous analysis of its (semi-)polar metabolome and lipidome from a single tissue aliquot are lacking. We developed and validated a dual-extraction method for metabolomics and lipidomics analyses of human placenta.,A Design of Experiments approach was based on 54 targeted metabolites and lipids (log P=–3.24-10.59) and untargeted feature count to optimize bead mill homogenization, solvent composition and dilution for sequential extraction, prior to ultra-high performance liquid chromatography coupled to high-resolution mass spectrometry. Method validation was performed on pooled porcine (as a proxy) and human placenta samples. Targeted validation demonstrated a coefficient of variation (CV) ≤20% for repeatability and inter-day precision and a coefficient of determination (R²) ≥0.99 for >26/27 metabolites and >17/27 lipids. Untargeted analysis consistently detected 2,811 and 5,412 features (CV ≤30%) in metabolite and lipid fractions, respectively.,The method was applied to 371 placental samples from the ENVIRONAGE birth cohort to assess metabolic perturbations associated with maternal lifestyle factors and adverse neonatal outcomes (small for gestational age (SGA) status, preterm birth, and low 1-minute Appearance, Pulse, Grimace, Activity and Respiration (APGAR)). Notably, placental cotinine levels showed associations with self-reported maternal smoking behavior (η² =0.14, FDR p <0.2). Pathway enrichment and targeted analyses identified outcome-specific metabolic signatures under basic covariate adjustment, though these were sensitive to extended covariate correction.,Our validated dual-extraction platform enables reproducible, resource-efficient placental phenotyping with demonstrated sensitivity to exposome signals, supporting large-scale birth cohort research into adverse neonatal outcomes.

  • Open Access

    Robust Metabolomics Data Normalization across Scales and Experimental Designs

    by Matthijs Vynck, Pablo Vangeenderhuysen, Ellen De Paepe, Tim Nawrot, Vera Plekhova, Lynn Vanhaecke

    Metabolomics studies employing liquid chromatography-mass spectrometry are affected by signal drift and batch effects, introducing technical variance that impedes biological knowledge discovery. Quality control (QC) sample-based normalization strategies are widely implemented but remain vulnerable to outliers, thereby reducing normalization performance. We introduce rLOESS, rGAM, and tGAM, three robust normalization methods that improve resistance to outliers by downweighting or accommodating them. Leveraging additive models, the rGAM and tGAM methods allow flexible nonlinear modeling, differential sample weighting, and data-driven QC representativeness evaluation. Implementations of these methods are gathered in the Metanorm R package, integrating robust normalization with visualization for performance verification while supporting efficient parallel processing. In in silico and/or experimental data sets, the robust methods, relative to several popular existing strategies, improved replicate concordance and reduced drift and batch effects. The robust methods, with improved recovery of the underlying signal demonstrated in simulation, produced distinct differential abundance results, highlighting the impact of normalization on downstream statistical inference. Overall, tGAM-based normalization suggested the best performance across scenarios and is proposed as the default choice. Metanorm is versatile, supporting normalization in metabolomics studies across scales and experimental setups. Metanorm is freely available at https://github.com/UGent-LIMET/Metanorm.


  • Open Access

    Challenges and Good Practices in Preprocessing and Normalization of Untargeted DNA Adductomics Data in Exposomics Research

    by Pablo Vangeenderhuysen, Matthijs Vynck, Liesa Engelen, Adrian Covaci, Tim Nawrot, Trancizeo Lipenga, Roger Pero-Gascon, Sarah De Saeger, Marthe De Boevre, Valerie McCormack, et al.

    DNA adductomics is the study of the whole of DNA adducts in a biological sample and is a valuable asset to exposomics research. To date, a clear view on how to analyze larger sample series is lacking in DNA adductomics, and the preprocessing of untargeted DNA adductomics data is seldom applied. This work aimed to optimize a DNA adductomics data preprocessing workflow (in true untargeted mode). Building upon the xcms R package, we optimized parameters for peak detection, retention time alignment, and peak grouping to reliably detect and integrate putative DNA adduct LC-MS peaks. Next, to ensure reliable downstream data analysis, six sample- and feature-based normalization methods were tested and quantitatively evaluated in two data sets (placental tissue, n = 375, and blood samples, n = 51). As a result, a successful and reproducible procedure for optimization of xcms parameters for DNA adductomics is proposed. Furthermore, evaluation of normalization methods demonstrated the importance and limitations of objective (RSD* and D-ratio) and subjective, i.e., visual (PCA score plot) evaluation. This work supports reproducible and transparent untargeted DNA adductomics data preprocessing to be implemented in large-scale exposomics studies.

  • Validation and clinical study of single-step vitrification combined with single-step warming of human blastocysts

    by Jan Gunst, Hubert Joris, Matthijs Vynck, Kristof Godderis, Martine Vercammen, Sylvie Roggeman, Arne van de Vijver

    This study assesses the feasibility of single-step vitrification and warming (SSV/SSW) for human blastocysts. Previous animal study models have shown possi

  • Standardized digital PCR assay validation using PCR-ValiPal, demonstrated in cross-platform quantification of bovine papilloma virus

    by David Gleerup, Matthijs Vynck, Lien Gysens, Cindy De Baere, Wim Trypsteen, Jo Vandesompele, Olivier Thas, Ann Martens, Maarten Haspeslagh, Ward De Spiegelaere


  • Open Access

    A repository of the salivary metabolome and its key drivers in 1436 European children

    by Ellen De Paepe, Emile Callemeyn, Kimberly De Windt, Kathleen Wijnant, Vera Plekhova, Beata Pomian, Pablo Vangeenderhuysen, Stefaan De Henauw, Nathalie Michels, Heli Viljakainen, et al.


  • Open Access

    Robust metabolomics data normalization across scales and experimental designs

    by Matthijs Vynck, Pablo Vangeenderhuysen, Ellen De Paepe, Tim Nawrot, Vera Plekhova, Lynn Vanhaecke

    Metabolomics studies employing liquid chromatography-mass spectrometry are affected by signal drift and batch effects, introducing technical variance that impedes biological knowledge discovery. Quality control (QC) sample-based normalization strategies are widely implemented but remain vulnerable to outliers, thereby reducing normalization performance. We introduce rLOESS, rGAM and tGAM, three robust normalization methods that improve resistance to outliers by downweighting or accommodating them. Leveraging additive models, the rGAM and tGAM methods allow flexible non-linear modeling, differential sample weighting, and data-driven QC representativeness evaluation. Implementations of these methods are gathered in the Metanorm R package, integrating robust normalization with visualization for performance verification, while supporting efficient parallel processing. Spanning in silico and experimental datasets, the robust methods, relative to existing strategies, consistently demonstrated a reduction in false positive and false negative differentially abundant metabolites, improved replicate concordance, and reduced batch effects. Metanorm is versatile, supporting normalization in metabolomics studies across scales and experimental setups.

  • Open Access

    Cross-platform digital PCR evaluation of bovine papilloma virus quantification: introducing PCR-ValiPal for Standardized guided assay validation

    by David Gleerup, Matthijs Vynck, Lien Gysens, Cindy De Baere, Jo Vandesompele, Olivier Thas, Ann Martens, Maarten Haspeslagh, Ward De Spiegelaere

    Digital Polymerase chain reaction (dPCR) enables precise and absolute quantification of nucleic acids by partitioning samples into thousands of individual PCR micro-reactions. While it minimizes the need for standard curves and enhances reproducibility compared to qPCR, thorough assay validation remains crucial. We introduce PCR-ValiPal, a user-friendly web application that standardizes dPCR assay validation steps and streamlines calculations of limit of blank (LOB), limit of detection (LOD), limit of quantification (LOQ), precision, trueness, and linearity in accordance with International Organization for Standardization (ISO) 20395:2019. To demonstrate PCR-ValiPal’s capabilities and the value of method-specific optimization, we use it to validate a novel three-color PCR assay for Bovine Papillomavirus (BPV) types 1 and 2, comparing four platforms: Naica (droplet dPCR), QIAcuity (microwell dPCR), LOAA (real-time dPCR), and CFX96 (qPCR). Using synthetic standards, we assess the platforms’ performance under identical assay conditions. Naica and QIAcuity showed lower LOB and LOQ values, along with minimal bias for BPV-1, while LOAA demonstrated stable but negative bias. Although qPCR exhibited the highest sensitivity for BPV-2, it was less sensitive at low concentrations for BPV-1. These results underscore the value of method-specific optimization and the usefulness of PCR-ValiPal.


  • Open Access

    Automated Integration and Quality Assessment of Chromatographic Peaks in LC–MS-Based Metabolomics and Lipidomics Using TARDIS

    by Pablo Vangeenderhuysen, Matthijs Vynck, Beata Pomian, Kimberly De Windt, Emile Callemeyn, Ellen De Paepe, Lindsey De Commer, Jeroen Raes, Tim Nawrot, Johannes Rainer, et al.

    In recent years, liquid chromatography coupled to mass spectrometry (LC-MS) has emerged as the main technology to measure the whole of small molecules (the metabolome) in a diversity of matrices. Within the field of computational metabolomics, significant efforts have been made in the development of tools to (pre)process untargeted LC-MS data. However, tools that circumvent the time-consuming, manual preprocessing of targeted LC-MS data with vendor-specific software remain sparse. We therefore present TARDIS, an open-source R package for the analysis of targeted LC-MS metabolomics and lipidomics data. Both established (area under the curve, maximum intensity and points over the peak) and recently developed (custom signal-to-noise ratio and bell-curve similarity) quality metrics were included to offer increased efficiency of peak quality evaluation. The robustness of TARDIS' peak integration was demonstrated through a quantitative comparison to state-of-the-art vendor software. To this end, applicability at a large scale (n = 1786) was validated across three distinct biofluids (stool, saliva and urine) and two LC-MS instruments, using data from the FAME, ENVIRONAGE, and FGFP cohort studies. In conclusion, TARDIS offers a robust and scalable open-source solution for the targeted analysis of LC-MS metabolomics and lipidomics data. TARDIS and its source code are freely available at https://github.com/UGent-LIMET/TARDIS.


  • The Poly (ADP‐Ribose) Polymerase‐1 Enzyme Is Overexpressed in Various Solid Canine Tumours: An Immunohistochemical Study

    by Shana De Vos, Simone Janssen, Sophie Favril, Hilde De Cock, Matthijs Vynck, Jonas Steenbrugge, Ward De Spiegelaere, Hilde de Rooster

    The enzyme poly (ADP‐ribose) polymerase‐1 (PARP‐1) is crucial for cellular regulation and DNA repair. Its immunohistochemical overexpression is known in various human neoplasms, but it was not yet a topic of veterinary research. Formalin‐fixed paraffin‐embedded canine samples of 15 controls and 34 tumours were immunohistochemically tested for PARP‐1 expression. Controls included five skin samples with mast cells, five oral mucosa samples and five thyroid glands. Tumours included 18 mast cell tumours (MCTs), 10 oral squamous cell carcinomas (SCCs) and six follicular thyroid carcinomas. A board‐certified veterinary pathologist defined the optimal region for the blind PARP‐1 evaluation, assessed by two independent veterinary PhD students. Positive nuclei were evaluated by the immunoreactivity score (IRS) and quick score (QS) and, for both scores, the averages of the two observers were used for statistical analysis. In all MCTs, 6/10 SCCs and all thyroid carcinomas as well as four thyroid controls a nuclear expression was observed. A cytoplasmic granular staining was visible in all dermal mast cells and in 11/18 MCTs due to non‐specific antibody uptake. No PARP‐1 was expressed in 11/15 controls.Compared to the controls, thyroid carcinomas significantly overexpressed PARP‐1 when calculated by IRS and QS (p = 0.003 and p = 0.005, respectively). The latter also applied to the MCTs (p = 0.001). A significantly higher PARP‐1 IRS and QS were observed in thyroid carcinomas (p = 0.003, p = 0.005) and MCTs (p = 0.003, p = 0.012) compared to oral SCCs. The immunohistochemical PARP‐1 overexpression in these tumours invites further research to assess its potential as a therapeutic target.